aod9604 fat loss efficacy clinical trials AOD-9604: Weight Loss, Evidence, Safety

Once taken, AOD 9604 peptide stimulates the pituitary gland, mimicking the human growth hormone and speeding up the bodys metabolism

Derived from a segment of the HGH molecule, it is touted to promote lipolysis (fat breakdown) without affecting lean muscle mass

The trial results noted minor improvement exhibited in the subjects cholesterol profiles and glucose tolerance levels

employed in osteoarthritis and cartilage regeneration research Pigs Used for pharmacokinetic profiling and oral bioavailability studies Cynomolgus monkeys 9-month chronic toxicology studies via oral gavage Human subjects Approximately 900 participants across six clinical trials examining safety and efficacy Research Limitations & Regulatory Status Critical Gaps in Current Evidence Despite over 25 years of research and extensive clinical testing, AOD-9604 faces substantial evidence gaps that have prevented therapeutic development